Alping P, Burman J, Lycke J, Frisell T, et al. Safety of Alemtuzumab and Autologous Hematopoietic Stem Cell Transplantation Compared to Non-induction Therapies for Multiple Sclerosis. Neurology 2021 Jan 29. pii: WNL.0000000000011545.
PMID: 33514645